SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

• Published in: The Lancet. Microbe Vol. 2; no. 7; pp. e283 - e284
• Main Authors: Jangra, Sonia, Ye, Chengjin, Rathnasinghe, Raveen, Stadlbauer, Daniel, Alshammary, Hala, Amoako, Angela A., Awawda, Mahmoud H., Beach, Katherine F, Bermúdez-González, Maria C., Chernet, Rachel L., Eaker, Lily Q., Ferreri, Emily D., Floda, Daniel L., Gleason, Charles R., Kleiner, Giulio, Jurczyszak, Denise, Matthews, Julia C., Mendez, Wanni A., Mulder, Lubbertus C.F., Russo, Kayla T., Salimbangon, Ashley-Beathrese T., Saksena, Miti, Shin, Amber S., Sominsky, Levy A., Srivastava, Komal, Krammer, Florian, Simon, Viviana, Martinez-Sobrido, Luis, García-Sastre, Adolfo, Schotsaert, Michael
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.07.2021; The Author(s). Published by Elsevier Ltd; Elsevier
• Subjects: Antibodies, Neutralizing - genetics; Correspondence; COVID-19; Humans; Infectious Disease; Mutation; SARS-CoV-2 - genetics; Spike Glycoprotein, Coronavirus - genetics